Last reviewed · How we verify
NCT05889026
The Effect of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity
NA trial testing Extracorporeal shock wave therapy in Stroke in 16 participants. Completed in 8 September 2021.
8 September 2021
Quick facts
| Lead sponsor | Korea University Guro Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 16 |
| Start date | 6 August 2020 |
| Primary completion | 8 September 2021 |
| Estimated completion | 8 September 2021 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Extracorporeal shock wave therapy
- Botulinum toxin treatment
Conditions studied
- Stroke — all drugs for Stroke →
- Hemiplegia, Spastic — all drugs for Hemiplegia, Spastic →
- Muscle Spasticity — all drugs for Muscle Spasticity →
Sponsor
Korea University Guro Hospital
Who can join
Adults 19 to 80, any sex, with Stroke or Hemiplegia, Spastic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There are few studies on whether botulinum toxin treatment and extracorporeal shock wave therapy are more effective than botulinum toxin alone treatment for post-stroke spasticity.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effectiveness of Extracorporeal Shock Wave Therapy after Botulinum Toxin Injection for Post-Stroke Upper Extremity Spasticity: A Randomized Controlled Study.
Lee J, Yang SN. · · 2024 · cited 4× · PMID 38668622 · DOI 10.3390/toxins16040197
Verify or expand the search:
- PubMed search for NCT05889026
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Extracorporeal shock wave therapy
Trials testing the same drug.
- NCT07468734 — Shock Wave Versus Traditional Physical Therapy for Adult Chronic Knee Osteoarthritis · NA · recruiting
- NCT06469931 — Ozone Therapy in Patients With Carpal Tunnel Syndrome · NA · recruiting
- NCT06329154 — Clinical Study On Extracorporeal Shock Wave Therapy For Rotator Cuff Injuries · NA · unknown
- NCT06248905 — Shock Wave Therapy Plus Exercise in GTPS · NA · active not recruiting
- NCT06067659 — Comparison Of The Treatment Effects Of Different Methods In Patients With Calcaneal Spur · NA · completed
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other Korea University Guro Hospital trials
Trials by the same sponsor.
- NCT07009769 — AI-Driven Precision Diagnostic System for Lung Cancer Based on Liquid Biopsy · completed
- NCT06752733 — Cardiac Stunning After Electrical Cardioversion · active not recruiting
- NCT06202690 — SP Robotic Versus VATS Anatomical Pulmonary Resection for Patients With NSCLC · NA · not yet recruiting
- NCT06889259 — Efficacy and Safety of CBT on Tinnitus · NA · completed
- NCT05704621 — Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Mai · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05889026 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Korea University Guro Hospital
- Last refreshed: 5 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05889026.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing